ZLAB
HEALTHCAREZai Lab Ltd
AI Insight
What's Moving ZLAB Today?
No stock-specific AI insight has been generated for ZLAB yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$15.96$41.20
$18.37
Fundamentals
Market Cap$2.1B
P/E Ratio—
EPS$-1.70
Dividend Yield—
Dividend / Share—
ROE-24.2%
Profit Margin-39.3%
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding112.4M
ZLAB News
25 articles- NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026?Motley Fool·Jun 22, 2026
- Zai Lab Receives EMA Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine CarcinomasYahoo Finance·Jun 16, 2026
- Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday TradingYahoo Finance·Jun 10, 2026
- Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical CancerYahoo Finance·Jun 9, 2026
- Zai Lab (ZLAB) Is Down 6.0% After Leadership Shake-Up And 2026 Data Focus Has The Bull Case Changed?Yahoo Finance·Jun 6, 2026
- Zai Lab (ZLAB) Announces Senior Leadership ChangesYahoo Finance UK·Jun 5, 2026
- Zai Lab Ltd stock (US98887Q1040): Nasdaq-listed biotech trades lower after Q1 2026 update and aheadAd Hoc News·Jun 2, 2026
- Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Up for WeekYahoo Finance·May 29, 2026
- Zai Lab's Josh Smiley to Cease Serving as President and COO; Samantha Du Assumes ResponsibilitiesTradingView·May 22, 2026
- Zai Lab Announces Changes to Senior Leadership TeamYahoo Finance·May 21, 2026
- Ying Du files Form 144 to sell ADS blocks (ZLAB)Stock Titan·May 19, 2026
- Asian Equities Traded in the US as American Depositary Receipts Lower in Monday TradingYahoo Finance·May 18, 2026
- Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday TradingYahoo Finance·May 15, 2026
- Asian Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday TradingYahoo Finance·May 11, 2026
- Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To KnowYahoo Finance·May 11, 2026
- Zai Lab Receives U.S. FDA Fast Track Designation for Zocilurtatug Pelitecan (Zoci), a DLL3-Targeting ADC, for Treatment of Extrapulmonary Neuroendocrine Carcinomas (epNECs)Yahoo Finance·May 11, 2026
- Zai Lab (ZLAB) Losses Of US$175.5 Million Test Bullish Earnings Turnaround NarrativeSimply Wall Street·May 9, 2026
- Zai Lab Q1 Earnings Call HighlightsMarketbeat·May 9, 2026
- Asian Equities Traded in the US as American Depositary Receipts Edge Higher FridayYahoo Finance·May 8, 2026
- Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to SayYahoo Finance·May 7, 2026
- Zai Lab Announces First Quarter 2026 Financial Results and Recent Corporate UpdatesYahoo Finance·May 7, 2026
- Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday TradingYahoo Finance·Apr 30, 2026
- Asian Equities Traded in the US as American Depositary Receipts Flat in Wednesday TradingYahoo Finance·Apr 29, 2026
- Assessing Zai Lab (ZLAB) Valuation After Recent Share Price Momentum And Analyst Target ResetYahoo Finance·Apr 28, 2026
- Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine CarcinomasGlobeNewswire Inc.·Apr 15, 2026
All 25 articles loaded
Price Data
Open$18.45
Previous Close$18.49
Day High$18.72
Day Low$18.21
52 Week High$41.20
52 Week Low$15.96
52-Week Range
$15.96$41.20
$18.37
Fundamentals
Market Cap$2.1B
P/E Ratio—
EPS$-1.70
Dividend Yield—
Dividend / Share—
ROE-24.2%
Profit Margin-39.3%
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding112.4M
About Zai Lab Ltd
Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops and markets therapies to treat cancer, autoimmune and infectious diseases in China. The company is headquartered in Shanghai, China.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—